Side-by-side comparison of AI visibility scores, market position, and capabilities
Oshi Health is a virtual-first gastroenterology care platform providing multidisciplinary treatment for IBS, Crohn's disease, ulcerative colitis, and other GI conditions; raised $60M+ total including a $30M Series B in 2022;
Oshi Health is a New York-based digital health company founded in 2018 by Sam Holliday that delivers virtual, multidisciplinary care for chronic digestive and gastrointestinal (GI) conditions. The platform connects patients with an integrated care team — including gastroenterologists, GI-specialized registered dietitians, behavioral health coaches, and care coordinators — to provide comprehensive, ongoing treatment for conditions such as irritable bowel syndrome (IBS), Crohn''s disease, ulcerative colitis, GERD, and functional GI disorders. Care is delivered virtually through telehealth visits, asynchronous messaging, and a patient app that tracks symptoms and supports between-visit adherence.
Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.